FREDUN · Fredun Pharmaceuticals Limited · Financials
Market Cap
25.37B INR
Shares
16.90M
Volume · Nov 13
6426
Avg daily vol (3M)
15.35K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
6.33B
+40.2%
FY2026
Net Income
326.21M
FY2026
Operating Cash Flow
262.77M
+190.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 8.64B | 6.33B | 4.52B |
| INR | 124.33M | 82.47M | 50.39M |
| INR | 424.29M | 392.98M | 223.77M |
| INR | 754.53M | 469.96M | 274.94M |
| INR | 224.89M | 143.75M | 77.54M |
| INR | 107.8M | 326.21M | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.